Ee. Bullesbach et C. Schwabe, THE CHEMICAL SYNTHESIS OF RAT RELAXIN AND THE UNEXPECTEDLY HIGH POTENCY OF THE SYNTHETIC HORMONE IN THE MOUSE, European journal of biochemistry, 241(2), 1996, pp. 533-537
Rat relaxin, as isolated from ovaries, has been described in the liter
ature as a low potency hormone in the mouse symphysis pubis assay. Sea
rching for an explanation, a helix-breaking glycine residue in the B c
hain seemed to be the most auspicious perturbation. Rat relaxin was ch
emically synthesized and analyzed by reverse-phase high performance li
quid chromatography, amino acid composition, mass spectrometry and cir
cular dichroic spectroscopy. Analogs of rat relaxin were synthesized e
ither with aspartic acid in place of the helix-breaking glycine residu
e in the receptor-binding region of the B chain or with Asp-Leu-Val in
stead of Gly-Tyr-Val at positions B14-B16. In receptor-binding assays
[B14D, B15L, B16V]relaxin was a better ligand than rat relaxin, wherea
s the [B14D]relaxin was less potent. In the mouse symphysis pubis assa
y, both analogs were less potent than unmodified rat relaxin, but the
[B14D, B15L, B16V]relaxin was better than [B14D]relaxin. In contrast t
o previous reports on native rat relaxin, the chemically synthesized r
at relaxin Droved to be as active as human and porcine relaxin with re
spect to the standard mouse assay system. Glycine, which is considered
to be a perturbator in an a helix, is not only tolerated in the B14 p
osition but is required for full biological potency.